Skip to main content
Log in

Ensure a comprehensive approach when treating drug-resistant tuberculosis

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I
Table II

References

  1. Global tuberculosis control 2010. Geneva: World Health Organization, 2010

  2. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Geneva: World Health Organization, 2010

  3. Albanna AS, Menzies D. Drug-resistant tuberculosis: what are the treatment options? Drugs 2011 May; 71(7): 815–25

    Article  PubMed  CAS  Google Scholar 

  4. Gurumurthy P, Ramachandran G, Hemanth Kumar AK, et al. Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin Infect Dis 2004 Jan 15; 38(2): 280–3

    Article  PubMed  CAS  Google Scholar 

  5. Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008. Geneva: World Health Organization, 2008

  6. Treatment of tuberculosis: guidelines. 4th ed. Geneva: World Health Organization, 2010

  7. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3: S231–79

    PubMed  CAS  Google Scholar 

  8. Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med 2009 Sep; 6(9): e1000146

    Article  PubMed  Google Scholar 

  9. Fitzpatrick C, Floyd K. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics 2012; 30(1): 63–80

    Article  PubMed  Google Scholar 

  10. Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009 Apr; 33(4): 871–81

    Article  PubMed  CAS  Google Scholar 

  11. Kim SJ, Espinal MA, Abe C, et al. Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuberc Lung Dis 2004 Sep; 8(9): 1157–8

    PubMed  CAS  Google Scholar 

  12. Dheda K, Warren RM, Zumla A, et al. Extensively drug-resistant tuberculosis: epidemiology and management challenges. Infect Dis Clin North Am 2010 Sep; 24(3): 705–25

    Article  PubMed  Google Scholar 

  13. Weis SE, Slocum PC, Blais FX, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994 Apr 28; 330(17): 1179–84

    Article  PubMed  CAS  Google Scholar 

  14. Mathew JL. Fixed dose drug combination for treatment of tuberculosis. Indian Pediatr 2009 Oct; 46(10): 877–80

    PubMed  Google Scholar 

  15. Mitnick C, Bayona J, Palacios E, et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N Engl J Med 2003 Jan 9; 348(2): 119–28

    Article  PubMed  Google Scholar 

  16. Dheda K, Shean K, Zumla A, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet 2010 May 22; 375(9728): 1798–807

    Article  PubMed  Google Scholar 

  17. Pomerantz BJ, Cleveland Jr JC, Olson HK, et al. Pulmonary resection for multi-drug resistant tuberculosis. J Thorac Cardiovasc Surg 2001 Mar; 121(3): 448–53

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ensure a comprehensive approach when treating drug-resistant tuberculosis. Drugs Ther Perspect 28, 15–18 (2012). https://doi.org/10.2165/11606270-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11606270-000000000-00000

Navigation